Open Randomized Clinical Trial on JWSJZ Decoction for the Treatment of ALS Patients

Table 1

Baseline clinical characteristics of the two ALS groups.

Subjects	JWSJZ group (𝑛=23)	Control group (𝑛=19)	𝑃 value
Age (years)	51.6 ± 7.2	50.1 ± 4.2	0.89
Men/Women	14/9	11/8	—
Disease duration (months)	25.9 ± 24.7	26.1 ± 24.9	0.37
Mean time from diagnosis (months)	18.35 ± 16.78	17.59 ± 13.51	0.29
Area where ALS first developed—limbs/bulbar/both	18/3/3	19/2/3	—
ALSFRS	37.1 ± 7.6	37.4 ± 9.2	0.65